Solactive BBVA Health & Wellness Index
Overview
The Covid-19 pandemic has impacted people’s life in every way, but mainly, it has prompted a global awareness on the importance of health.
With a society long-time concerned with aging and healthcare affordability, a renewed interest for disease “prevention” over “treatment” is growing rapidly; thus, paving the way for innovative therapies and major advancements in biopharmaceuticals, medical technology and consumer care products and services.
Solactive BBVA Health & Wellness Index selects companies taking human health at its heart; leading the fight against infectious and chronic diseases, serving the needs of the elder, refining healthcare management and favouring a healthy lifestyle and well-being.
Key Metrics
Category
Thematic
Megatrend
Future Healthcare
Asset Class
Equity
Region
Global
Weighting
Overweights Health
Revenue exposure
# Constituents
50
Key Facts
- Global Health & Wellness Exposure
- Comprehensive selection process considering 149 sub-industries
- Ranking based on x-trend and single trend value drivers
- Revenue data provided by Factset
- Market cap weighted tilted by Health & Wellness revenues
- Available version specially crafted for investors who prefer a hedged version in Mexican Peso and require constituents to be listed in the Sistema Internacional de Cotizaciones (SIC)
Disclaimer
DISCLAIMER Solactive
The financial instrument is not sponsored, promoted, sold or supported in any other manner by Solactive AG nor does Solactive AG offer any express or implicit guarantee or assurance either with regard to the results of using the Index and/or Index trade mark or the Index Price at any time or in any other respect. The Index is calculated and published by Solactive AG. Solactive AG uses its best efforts to ensure that the index is calculated correctly. Irrespective of its obligations towards the Issuer, Solactive AG has no obligation to point out errors in the Index to third parties including but not limited to investors and/or financial intermediaries of the financial instrument. Neither publication of the Index by Solactive AG nor the licensing of the Index or Index trade mark for the purpose of use in connection with the financial instrument constitutes a recommendation by Solactive AG to invest capital in said financial instrument nor does it in any way represent an assurance or opinion of Solactive AG with regard to any investment in this financial instrument.